Premier Path Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $817K | Buy |
1,835
+45
| +3% | +$20K | 0.11% | 190 |
|
|
2025
Q1 | $868K | Buy |
1,790
+104
| +6% | +$50.4K | 0.14% | 178 |
|
|
2024
Q4 | $679K | Buy |
1,686
+80
| +5% | +$32.2K | 0.1% | 193 |
|
|
2024
Q3 | $747K | Buy |
1,606
+28
| +2% | +$13K | 0.12% | 180 |
|
|
2024
Q2 | $740K | Buy |
1,578
+174
| +12% | +$81.6K | 0.13% | 173 |
|
|
2024
Q1 | $587K | Buy |
1,404
+18
| +1% | +$7.53K | 0.11% | 185 |
|
|
2023
Q4 | $564K | Buy |
+1,386
| New | +$564K | 0.12% | 175 |
|